<DOC>
	<DOCNO>NCT01409096</DOCNO>
	<brief_summary>Primary purpose study determine pregnenolone supplementation associate great improvement depressive symptom patient bipolar disorder . Also study explore possibility improve anxiety manic symptom well patient 's cognition .</brief_summary>
	<brief_title>Study Using Pregnenolone Treat Bipolar Depression</brief_title>
	<detailed_description>Determine pregnenolone supplementation associate great improvement depressive symptom placebo person Bipolar Depression ( BPD ) , depressed phase . In pilot study , pregnenolone show strong signal depression score . Secondary 1 . Determine pregnenolone supplementation associate great improvement anxiety symptom person BPD , depress phase . Data prior study suggest pregnenolone may decrease symptom anxiety . Anxiety common clinically important feature BPD . Therefore , examine anxiety symptom trial . 2 . Determine pregnenolone supplementation associate improvement manic symptom compare placebo person BPD , depress phase . Our pilot study suggest pregnenolone may associate improvement manic symptom . Although current study target bipolar depression also examine manic symptom .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Men Women race age 1875 year Diagnosis bipolar I , II otherwise specify ( NOS ) disorder currently meet criterion major depressive episode English speaking Active suicidal ideation plan intent Treatment resistant depression Vulnerable population ( i.e . pregnant , cognitively impaired , incarcerate ) Severe life threaten medical condition History allergic reaction side effect prior pregnenolone use Current substance use disorder define meet criterion abuse dependence base Structured Clinical Interview Diagnostic Statistical Manual ( DSM ) ( SCID ) interview selfreported use within past 3 month positive baseline urine drug screen Removal addition concomitant psychiatric medication within 10 day prior randomization Current Warfarin therapy Current use oral contraceptive Current hormone replacement therapy History heart disease arrhythmias Current ( past 7 day ) systemic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>